"Linda D. Misek-Falkoff, Ph.D., J.D." <[EMAIL PROTECTED]> writes:
Ron - Thanks for the response; makes sense to me (about the inhibitory
effect, possibly, on new formations) and is more detailed than anything
I've been hearing. Sure is nice to have on the list both a medical person
and one who can communicate (oh, and is willing to share). :-) LDMF.
--------------------Ronald Helm wrote:--------------------------------
>
> "Ronald Helm" <[EMAIL PROTECTED]> writes:
>
> >Hi Ron, Doc - a simplistic question, hope you don't mind replying: how
> >are healthy blood flow channels preserved, that is there seems to be a
> >special targeting. Do you know how this is achieved with these drugs?
> >Thanks :) LDMF.
>
> I wish I could answer that question. These angiogenesis inhibitors, must
> only prevent new vessel formation, and that is why they could not be used in
> pregnant women where a fetus is developing its circulatory system. Also
> adults develop collateral circulation, for example after coronary occlusion
> or bypass, new vessels develop to supply the myocardium. I suspect that
> this process would be inhibited by these medicines. Ron
>
> 99 percent of lawyers give the rest a bad name.
> [EMAIL PROTECTED]
>
> Subscribe/Unsubscribe, email: [EMAIL PROTECTED]
> In the body of the message enter: subscribe/unsubscribe law-issues
Subscribe/Unsubscribe, email: [EMAIL PROTECTED]
In the body of the message enter: subscribe/unsubscribe law-issues
